Followers | 231 |
Posts | 14703 |
Boards Moderated | 1 |
Alias Born | 03/29/2014 |
Wednesday, May 04, 2022 10:10:31 AM
It would be nice to see a large group of NWBO shareholders support the NYAS and sign-up for the live presentation of Dr. Liau to hear what she has to say.
I believe that the following passage was sent out in an email blast by the Frontiers in Cancer Immunotherapy. Having already signed up for the event, I'd have thought I would have received this email, but I didn't. I think, therefore, that it may have been in an email blast to either the press, or to actual NYAS members.
The below statement is from the Frontiers in Cancer Immunotherapy email blast:
It's my understanding that the New York Academy of Sciences has been very accommodating to Northwest Bio, given all their multiple balls in the air (e.g. Journal rules, NYAS rules, etc.), and contending trip wires (Lawyer rules, SEC rules) right now.
I believe that while any journal the company is working closely together with to publish the long-awaited trial data is okay with some of the data being presented by a non-employee (which Dr. Liau is) at a scientific conference, apparently, they are NOT okay with that same data being PR'd. It is not the business of these journals, who are, in a sense, the medical press, to be altruistic in their nature, with "red hot" news. They all want to be the ones breaking the "red hot" news in order to sell their journals, and the articles contained within them. So if the company wants to publish their results in a journal (which apparently has shown to improve one's chances of regulatory approval), they have to follow the rules of that particular journal.
Therefore, while the company may choose to PR the upcoming event LL will be speaking about, [I]it is now my understanding that they will NOT release the actual "exciting" content (I mean the data) that she will be discussing at this event as it will likely violate the rules of the journal.
It is likely that some in the press WILL cover this NYAS event, and so it is very possible LL's event will receive some press coverage.
So again, I hope various shareholders will sign up for the event which, IMO, would show support for Dr. Liau, NYAS, and the company. Plus, it seems, this represents an opportunity to hear some of the "exciting" updates on the P3 trial.
https://events.nyas.org/event/28ca5e39-51a7-4e73-be3d-78089c92d596/websitePage:6415ad40-8fcf-40db-8dc0-dde9ad5e065e
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM